Screening of Natural Products and Derivatives for the Identification RND Efflux of Pump Inhibitors

被引:17
作者
Choudhury, Debarati [1 ]
Das Talukdar, Anupam [1 ]
Chetia, Pankaj [2 ]
Bhattacharjee, Amitabha [3 ]
Choudhury, Manabendra Dutta [1 ]
机构
[1] Assam Univ, Dept Life Sci & Bioinformat, Silchar 788011, Assam, India
[2] Dibrugarh Univ, Dept Life Sci, Dibrugarh 786004, Assam, India
[3] Assam Univ, Dept Microbiol, Silchar 788011, Assam, India
关键词
Docking; Efflux Pump Inhibitors (EPI); MexAB-OprM; p-coumaric acid; Pseudomonas aeruginosa; RND efflux pumps; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; RESISTANT; PREDICTION; BACTERIA; DOCKING; PROTEIN;
D O I
10.2174/1386207319666160720101502
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aim and objective: Overexpression of efflux pumps belonging to the Resistance Nodulation cell Division (RND) family is the most important intrinsic resistance mechanism of Pseudomonas aeruginosa. Hence, it is imperative to identify suitable efflux pump inhibitors (EPI) that can lead to increased intracellular concentration of antibiotics by blocking the pump. This study was undertaken to identify a putative plant based efflux pump inhibitor for RND efflux pump of P. aeruginosa. Material and method: Using molecular docking approach, 328 secondary plant metabolites have been screened for their inhibitory activity against cytoplasmic exporter protein MexB of MexAB-OprM efflux pump of P. aeruginosa. After the initial in silico screening, the shortlisted compounds were subjected to in vitro test for efflux pump inhibitory activity using double disc synergy test. A combinatorial library of 1000 molecules was generated from active p-coumaric acid and docked with MexB protein to find a suitable EPI with better binding efficacy compared to the p-coumaric acid. Results: Preliminary screening resulted in five plant-based natural products with significant docking score and were subsequently subjected to double disc synergy test. p-Coumaric acid, amongst the five, was found to potentiate activity of ciprofloxacin in MexAB-OprM overexpressing P. aeruginosa strain. Library compound 482, i.e 4-(4-((Z)-2-carboxy-2-((Z)-2,3-dihydrobenzo[e][1,4]diazepin-l-yl)-1-(4-hydroxyphenyl)vinylamino) phenylsulfonamido)-2-hydroxybenzoic acid, a derivative of p-coumaric acid exhibited the highest docking score of-42.1030 Kcal/mol, which was much higher than parent compound (-17.9403 Kcal/mol) and also known EPI, MC-207,110 (-28.0960 Kcal/mol). Conclusion: p-Coumaric acid and its derivative, 4-(4-((Z)-2-carboxy-2-((Z)-2,3-dihydrobenzo[e][1,4] diazepin-l-yl)-1-(4-hydroxyphenyl)vinylamino)phenylsulfonamido)-2-hydroxybenzoic acid may be used as potential lead molecules for effective RND efflux pump inhibition in P. aeruginosa.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 25 条
[1]   Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies [J].
Alves, M. J. ;
Ferreira, I. C. F. R. ;
Froufe, H. J. C. ;
Abreu, R. M. V. ;
Martins, A. ;
Pintado, M. .
JOURNAL OF APPLIED MICROBIOLOGY, 2013, 115 (02) :346-357
[2]   Antimicrobial activity of wild mushroom extracts against clinical isolates resistant to different antibiotics [J].
Alves, M. J. ;
Ferreira, I. C. F. R. ;
Martins, A. ;
Pintado, M. .
JOURNAL OF APPLIED MICROBIOLOGY, 2012, 113 (02) :466-475
[3]   Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation [J].
Aparna, Vasudevan ;
Dineshkumar, Kesavan ;
Mohanalakshmi, Narasumani ;
Velmurugan, Devadasan ;
Hopper, Waheeta .
PLOS ONE, 2014, 9 (07)
[4]   Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa [J].
Askoura, Momen ;
Mottawea, Walid ;
Abujamel, Turki ;
Taher, Ibrahim .
LIBYAN JOURNAL OF MEDICINE, 2011, 6 :1-8
[5]   Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection [J].
Balani, SK ;
Miwa, GT ;
Gan, LS ;
Wu, JT ;
Lee, FW .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (11) :1033-1038
[6]   Predicting protein interaction sites: binding hot-spots in protein-protein and protein-ligand interfaces [J].
Burgoyne, Nicholas J. ;
Jackson, Richard M. .
BIOINFORMATICS, 2006, 22 (11) :1335-1342
[7]   Natural products: A continuing source of novel drug leads [J].
Cragg, Gordon M. ;
Newman, David J. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (06) :3670-3695
[8]   Virtual combinatorial chemistry and in silico screening: Efficient tools for lead structure discovery? [J].
Langer, T ;
Wolber, G .
PURE AND APPLIED CHEMISTRY, 2004, 76 (05) :991-996
[9]   Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites [J].
Laurie, ATR ;
Jackson, RM .
BIOINFORMATICS, 2005, 21 (09) :1908-1916
[10]   Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms [J].
Lister, Philip D. ;
Wolter, Daniel J. ;
Hanson, Nancy D. .
CLINICAL MICROBIOLOGY REVIEWS, 2009, 22 (04) :582-+